
Sign up to save your podcasts
Or
Introducing Dr. Ania Jastreboff from The Oprah Podcast.
Follow the show: The Oprah Podcast
In this episode of The Oprah Podcast, Oprah sits down with Dr. Ania Jastreboff, an endocrinologist and associate professor at the Yale School of Medicine, to talk about the new GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound. Dr. Ania, who has been on the forefront of GLP-1 medication research for the past 20 years, will talk through why it is biologically difficult for some people to lose weight, maintain weight loss and why obesity is a disease. She explains how the new GLP-1 medications work, how they can facilitate weight loss, and if they are safe. Dr. Ania answers questions from people around the country who are taking the GLP-medications and have lost a significant amount of weight. We will also share an update from Amy Kane who told her story of losing 160 pounds on weight loss medications last year on Oprah’s ABC Special: Shame, Blame and the Weight Loss Revolution.
Also referenced in this episode: "The Let Them Theory: A Life-Changing Tool That Millions of People Can’t Stop Talking About" by Mel Robbins, published by Hay House LLC is available wherever books and audio books are sold.
SUPPORT THE SHOW
Subscribe: https://www.youtube.com/@Oprah
Find Oprah’s Interview with Mel Robbins Here.
Follow Amy on Instagram
Follow Amy on TikTok
Follow Emma on TikTok
Follow Emma on Instagram
Follow Oprah Winfrey on Social:
Learn more about your ad choices. Visit megaphone.fm/adchoices
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].
4.6
629629 ratings
Introducing Dr. Ania Jastreboff from The Oprah Podcast.
Follow the show: The Oprah Podcast
In this episode of The Oprah Podcast, Oprah sits down with Dr. Ania Jastreboff, an endocrinologist and associate professor at the Yale School of Medicine, to talk about the new GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound. Dr. Ania, who has been on the forefront of GLP-1 medication research for the past 20 years, will talk through why it is biologically difficult for some people to lose weight, maintain weight loss and why obesity is a disease. She explains how the new GLP-1 medications work, how they can facilitate weight loss, and if they are safe. Dr. Ania answers questions from people around the country who are taking the GLP-medications and have lost a significant amount of weight. We will also share an update from Amy Kane who told her story of losing 160 pounds on weight loss medications last year on Oprah’s ABC Special: Shame, Blame and the Weight Loss Revolution.
Also referenced in this episode: "The Let Them Theory: A Life-Changing Tool That Millions of People Can’t Stop Talking About" by Mel Robbins, published by Hay House LLC is available wherever books and audio books are sold.
SUPPORT THE SHOW
Subscribe: https://www.youtube.com/@Oprah
Find Oprah’s Interview with Mel Robbins Here.
Follow Amy on Instagram
Follow Amy on TikTok
Follow Emma on TikTok
Follow Emma on Instagram
Follow Oprah Winfrey on Social:
Learn more about your ad choices. Visit megaphone.fm/adchoices
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].
1,618 Listeners
6,758 Listeners
30 Listeners
19,158 Listeners
10,939 Listeners
8,982 Listeners
2,263 Listeners
56 Listeners
97 Listeners
58 Listeners
7,578 Listeners
47 Listeners
43 Listeners
291 Listeners
15 Listeners
7,271 Listeners
28 Listeners
45 Listeners
42 Listeners
11 Listeners
8,513 Listeners
15 Listeners
18 Listeners
20 Listeners
2,966 Listeners
21 Listeners
13 Listeners
13 Listeners
12 Listeners
437 Listeners
1,731 Listeners
39 Listeners
212 Listeners
47 Listeners
107 Listeners